Annual Drug Patent Expirations for TALZENNA
Talzenna is a drug marketed by Pfizer and is included in one NDA. It is available from two suppliers. There are five patents protecting this drug.
This drug has seventy-nine patent family members in thirty countries.
The generic ingredient in TALZENNA is talazoparib tosylate. Two suppliers are listed for this compound. Additional details are available on the talazoparib tosylate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
